• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结节性硬化症患者从儿童期到成年期的医疗过渡。

Healthcare transition from childhood to adulthood in Tuberous Sclerosis Complex.

机构信息

Department of Health Sciences, Child Neuropsychiatry Unit - Epilepsy Center, San Paolo Hospital, Università degli Studi di Milano, Milan, Italy.

Department of Pediatrics, Division of Medical Genetics, University of Utah School of Medicine, Salt Lake City, Utah.

出版信息

Am J Med Genet C Semin Med Genet. 2018 Sep;178(3):355-364. doi: 10.1002/ajmg.c.31653. Epub 2018 Sep 25.

DOI:10.1002/ajmg.c.31653
PMID:30253036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6635672/
Abstract

Healthcare transition from childhood to adulthood is required to ensure continuity of care of an increasing number of individuals with chronic conditions surviving into adulthood. The transition for patients with tuberous sclerosis complex (TSC) is complicated by the multisystemic nature of this condition, age-dependent manifestations, and high clinical variability and by the presence of intellectual disability in at least half of the individuals. In this article, we address the medical needs regarding each TSC-related manifestation in adulthood, and the services and support required. We review existing models of transition in different chronic conditions, discuss our experience in transitioning from the pediatric to the adult TSC Clinic at our Institution, and propose general rules to follow when establishing a transition program for TSC. Although a generalizable transition model for TSC is likely not feasible for all Institutions, a multidisciplinary TSC clinic is probably the best model, developed in accordance with the resources available and country-specific healthcare systems. Coordination of care and education of the adult team should be always sought regardless of the transition model.

摘要

从儿童期到成年期的医疗保健过渡对于确保越来越多患有慢性疾病的人能够顺利过渡至关重要。患有结节性硬化症(TSC)的患者的过渡比较复杂,因为这种疾病具有多系统性质,与年龄相关的表现,以及高度的临床变异性,而且至少有一半的患者存在智力残疾。在本文中,我们将讨论成年人中与 TSC 相关的各种表现的医疗需求,以及所需的服务和支持。我们回顾了不同慢性疾病中现有的过渡模式,讨论了我们在将患者从儿科 TSC 诊所过渡到我们机构的成人 TSC 诊所的经验,并提出了在为 TSC 建立过渡计划时应遵循的一般规则。虽然对于所有机构来说,一个可推广的 TSC 过渡模式可能不可行,但多学科 TSC 诊所可能是最好的模式,该模式是根据可用资源和特定国家的医疗保健系统制定的。无论采用何种过渡模式,都应始终寻求护理协调和对成人团队的教育。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789a/6635672/e6d7018d600a/AJMG-178-355-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789a/6635672/d277186cada2/AJMG-178-355-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789a/6635672/e6d7018d600a/AJMG-178-355-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789a/6635672/d277186cada2/AJMG-178-355-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/789a/6635672/e6d7018d600a/AJMG-178-355-g002.jpg

相似文献

1
Healthcare transition from childhood to adulthood in Tuberous Sclerosis Complex.结节性硬化症患者从儿童期到成年期的医疗过渡。
Am J Med Genet C Semin Med Genet. 2018 Sep;178(3):355-364. doi: 10.1002/ajmg.c.31653. Epub 2018 Sep 25.
2
Experience of follow-up, quality of life, and transition from pediatric to adult healthcare of patients with tuberous sclerosis complex.结节性硬化症患者的随访体验、生活质量和从儿科到成人保健的过渡。
Epilepsy Behav. 2019 Jul;96:23-27. doi: 10.1016/j.yebeh.2019.04.027. Epub 2019 May 9.
3
Tuberous sclerosis complex: Concerns and needs of patients and parents from the transitional period to adulthood.结节性硬化症:从过渡期到成年期患者及家长的担忧与需求
Epilepsy Behav. 2018 Jun;83:13-21. doi: 10.1016/j.yebeh.2018.03.012. Epub 2018 Apr 7.
4
Long-term cognitive outcomes in tuberous sclerosis complex.结节性硬化症的长期认知结局。
Dev Med Child Neurol. 2020 Mar;62(3):322-329. doi: 10.1111/dmcn.14356. Epub 2019 Sep 19.
5
[Care continuity for patients with tuberous sclerosis complex (TSC) during transition from childhood to adulthood].[结节性硬化症(TSC)患者从儿童期到成年期过渡期间的照护连续性]
Nihon Rinsho. 2010 Jan;68(1):136-40.
6
Current management of tuberous sclerosis complex.结节性硬化症复合体的当前管理
Paediatr Drugs. 2008;10(5):299-313. doi: 10.2165/00148581-200810050-00004.
7
A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report.建立结节性硬化症多学科管理团队的逐步方法:德尔菲共识报告。
Orphanet J Rare Dis. 2019 Apr 30;14(1):91. doi: 10.1186/s13023-019-1072-y.
8
Shared decision-making and the caregiver experience in tuberous sclerosis complex: results from a UK survey.结节性硬化症患者共同决策和照顾者体验:来自英国调查的结果。
Orphanet J Rare Dis. 2023 Apr 11;18(1):78. doi: 10.1186/s13023-023-02677-7.
9
Characteristics and healthcare situation of adult patients with tuberous sclerosis complex in German epilepsy centers.德国癫痫中心成年结节性硬化症患者的特征与医疗状况
Epilepsy Behav. 2018 May;82:64-67. doi: 10.1016/j.yebeh.2018.03.006. Epub 2018 Mar 26.
10
Renal manifestations of tuberous sclerosis complex: patients' and parents' knowledge and routines for renal follow-up - a questionnaire study.结节性硬化症的肾脏表现:患者及家长对肾脏随访的认知与常规做法——一项问卷调查研究
BMC Nephrol. 2018 Feb 13;19(1):39. doi: 10.1186/s12882-018-0835-3.

引用本文的文献

1
A coordinated multidisciplinary model of care is needed for child and family centered care in pediatric genetic cancer risk services: a scoping review.儿科遗传癌症风险服务中以儿童和家庭为中心的护理需要一个协调的多学科护理模式:一项范围综述。
Fam Cancer. 2025 Jun 20;24(3):55. doi: 10.1007/s10689-025-00474-8.
2
mTOR pathway diseases: challenges and opportunities from bench to bedside and the mTOR node.mTOR信号通路疾病:从实验室到临床的挑战与机遇以及mTOR节点
Orphanet J Rare Dis. 2025 May 27;20(1):256. doi: 10.1186/s13023-025-03740-1.
3
Tuberous Sclerosis Complex: A Case Series from a Romanian Genetics Center and a Review of the Literature.

本文引用的文献

1
Transition from pediatric to adult care in adolescents with hereditary metabolic diseases: Specific guidelines from the French network for rare inherited metabolic diseases (G2M).遗传性代谢疾病青少年从儿科护理向成人护理的过渡:法国罕见遗传性代谢疾病网络(G2M)的特定指南。
Arch Pediatr. 2018 Jun 15. doi: 10.1016/j.arcped.2018.05.009.
2
Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex: The TREATMENT Randomized Clinical Trial.局部他莫昔芬治疗结节性硬化症相关面血管纤维瘤的疗效和安全性:一项 TREATMENT 随机临床试验。
JAMA Dermatol. 2018 Jul 1;154(7):773-780. doi: 10.1001/jamadermatol.2018.0464.
3
结节性硬化症:来自罗马尼亚遗传学中心的病例系列及文献综述
J Clin Med. 2025 Apr 25;14(9):2974. doi: 10.3390/jcm14092974.
4
Tuberous Sclerosis Complex: New Insights into Pathogenesis and Therapeutic Breakthroughs.结节性硬化症复合体:发病机制的新见解与治疗突破
Life (Basel). 2025 Feb 26;15(3):368. doi: 10.3390/life15030368.
5
Mortality in Tuberous Sclerosis Complex in the United Kingdom, 2016-2022.2016 - 2022年英国结节性硬化症复合体的死亡率
J Intellect Disabil Res. 2025 Jun;69(6):457-464. doi: 10.1111/jir.13225. Epub 2025 Mar 10.
6
Clinician perspectives on designing and implementing a hereditary cancer transition clinic.临床医生对遗传性癌症转诊诊所设计与实施的看法。
Hered Cancer Clin Pract. 2025 Jan 11;23(1):2. doi: 10.1186/s13053-024-00304-5.
7
Transition clinics in pediatric rheumatology in Colombia: reflection on a necessary shortcomings.哥伦比亚儿科风湿病过渡诊所:对必要缺陷的反思
Adv Rheumatol. 2025 Jan 2;65(1):1. doi: 10.1186/s42358-024-00419-2.
8
The pivotal role of neurosurgeons in transitional care: A comprehensive tertiary healthcare institution's experience.神经外科医生在过渡性护理中的关键作用:一家综合性三级医疗机构的经验。
Childs Nerv Syst. 2024 Dec;40(12):4271-4278. doi: 10.1007/s00381-024-06638-8. Epub 2024 Oct 5.
9
The importance of genetic counselling for turner syndrome transition.特纳综合征过渡期遗传咨询的重要性。
Eur Child Adolesc Psychiatry. 2025 Mar;34(3):943-958. doi: 10.1007/s00787-024-02547-y. Epub 2024 Aug 8.
10
Barriers to a successful healthcare transition for individuals with urea cycle disorders.尿素循环障碍患者成功过渡到医疗保健的障碍。
Mol Genet Metab. 2023 Jul;139(3):107609. doi: 10.1016/j.ymgme.2023.107609. Epub 2023 May 15.
Tuberous sclerosis complex: Concerns and needs of patients and parents from the transitional period to adulthood.
结节性硬化症:从过渡期到成年期患者及家长的担忧与需求
Epilepsy Behav. 2018 Jun;83:13-21. doi: 10.1016/j.yebeh.2018.03.012. Epub 2018 Apr 7.
4
Characteristics and healthcare situation of adult patients with tuberous sclerosis complex in German epilepsy centers.德国癫痫中心成年结节性硬化症患者的特征与医疗状况
Epilepsy Behav. 2018 May;82:64-67. doi: 10.1016/j.yebeh.2018.03.006. Epub 2018 Mar 26.
5
Renal manifestations of tuberous sclerosis complex: patients' and parents' knowledge and routines for renal follow-up - a questionnaire study.结节性硬化症的肾脏表现:患者及家长对肾脏随访的认知与常规做法——一项问卷调查研究
BMC Nephrol. 2018 Feb 13;19(1):39. doi: 10.1186/s12882-018-0835-3.
6
Deep phenotyping of patients with Tuberous Sclerosis Complex and no mutation identified in TSC1 and TSC2.结节性硬化症患者的深度表型分析以及未在TSC1和TSC2中鉴定出的突变
Eur J Med Genet. 2018 Jul;61(7):403-410. doi: 10.1016/j.ejmg.2018.02.005. Epub 2018 Feb 9.
7
Sclerotic bone lesions as a potential imaging biomarker for the diagnosis of tuberous sclerosis complex.硬化性骨病变作为一种潜在的影像学生物标志物用于结节性硬化症的诊断。
Sci Rep. 2018 Jan 17;8(1):953. doi: 10.1038/s41598-018-19399-7.
8
Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders.依维莫司用于治疗结节性硬化症相关神经精神障碍。
Ann Clin Transl Neurol. 2017 Nov 12;4(12):877-887. doi: 10.1002/acn3.494. eCollection 2017 Dec.
9
Barriers to Transition From Pediatric to Adult Care: A Systematic Review.从儿科到成人护理的过渡障碍:系统评价。
J Pediatr Psychol. 2018 Jun 1;43(5):488-502. doi: 10.1093/jpepsy/jsx142.
10
Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study.依维莫司在结节性硬化症患者中的长期应用:EXIST - 2研究的四年期更新
PLoS One. 2017 Aug 9;12(8):e0180939. doi: 10.1371/journal.pone.0180939. eCollection 2017.